87 related articles for article (PubMed ID: 21912107)
1. The ratio of adiponectin to HOMA as an index of metabolic syndrome in obese women.
de Luis DA; Aller R; Izaola O; Conde R; Gonzalez Sagrado M
Ann Nutr Metab; 2011 Oct; 58(4):301-6. PubMed ID: 21912107
[TBL] [Abstract][Full Text] [Related]
2. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Abdullah AR; Hasan HA; Raigangar VL
Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
[TBL] [Abstract][Full Text] [Related]
5. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
[TBL] [Abstract][Full Text] [Related]
7. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
[TBL] [Abstract][Full Text] [Related]
9. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome and insulin resistance in overweight and obese women according to the different diagnostic criteria.
Kocełak P; Chudek J; Olszanecka-Glinianowicz M
Minerva Endocrinol; 2012 Sep; 37(3):247-54. PubMed ID: 22766891
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
Seino Y; Hirose H; Saito I; Itoh H
Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
[TBL] [Abstract][Full Text] [Related]
13. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
14. Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.
Calcaterra V; Muratori T; Klersy C; Albertini R; Caramagna C; Brizzi V; Larizza D
Ann Nutr Metab; 2011 Oct; 58(4):307-14. PubMed ID: 21912108
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
González AS; Guerrero DB; Soto MB; Díaz SP; Martinez-Olmos M; Vidal O
Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
[TBL] [Abstract][Full Text] [Related]
16. Hypoadiponectinemia is associated with blood pressure increase in obese insulin-resistant individuals.
Francischetti EA; Celoria BM; Duarte SF; da Silva EG; Santos IJ; Cabello PH; Genelhu VA
Metabolism; 2007 Nov; 56(11):1464-9. PubMed ID: 17950095
[TBL] [Abstract][Full Text] [Related]
17. The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: the Korean Genomic Rural Cohort Study.
Yoon JH; Park JK; Oh SS; Lee KH; Kim SK; Cho IJ; Kim JK; Kang HT; Ahn SG; Lee JW; Lee SH; Eom A; Kim JY; Ahn SV; Koh SB
Clin Chim Acta; 2011 Nov; 412(23-24):2199-205. PubMed ID: 21855536
[TBL] [Abstract][Full Text] [Related]
18. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients.
Labruna G; Pasanisi F; Nardelli C; Caso R; Vitale DF; Contaldo F; Sacchetti L
Obesity (Silver Spring); 2011 Jul; 19(7):1492-6. PubMed ID: 21183936
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M
J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in a Mediterranean pediatric cohort: prevalence using International Diabetes Federation-derived criteria and associations with adiponectin and leptin.
Papoutsakis C; Yannakoulia M; Ntalla I; Dedoussis GV
Metabolism; 2012 Feb; 61(2):140-5. PubMed ID: 21816444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
